CollPlant Biotechnologies (CLGN) Debt to Equity (2017 - 2021)
CollPlant Biotechnologies (CLGN) reported Debt to Equity of $0.12 for Q3 2021, up 150.34% on a YoY basis from $0.05 in Q3 2020, and down 29.31% quarter-over-quarter from $0.17 in Q2 2021.
CollPlant Biotechnologies (CLGN) Debt to Equity (2017 - 2021) Analysis & Trends
CollPlant Biotechnologies has reported Debt to Equity for 5 years, with the latest figure at $0.12 in Q3 2021.
- For the quarter ending Q3 2021, Debt to Equity rose 150.34% year-over-year to $0.12; the trailing twelve-month figure through Sep 2021 stood at $0.12 (up 150.34% YoY), and the FY2020 full-year result was -$0.74, up 48.74% from the prior year.
- Debt to Equity for Q3 2021 stood at $0.12, down from $0.17 in the prior quarter.
- The five-year high for Debt to Equity was $0.7 in Q4 2017, with the low at -$1.45 in Q4 2019.
- Historically, Debt to Equity has averaged -$0.23 across 5 years, with a median of -$0.21 in 2020.
- Annual changes were most pronounced in 2019 — Debt to Equity tumbled 232.36% — and 2021, when it soared 209.65%.
- CollPlant Biotechnologies' Debt to Equity stood at $0.7 in 2017, then sank by 161.88% to -$0.44 in 2018, then plunged by 232.36% to -$1.45 in 2019, then soared by 48.74% to -$0.74 in 2020, then surged by 115.81% to $0.12 in 2021.
- The last three Debt to Equity figures came in at $0.12 (Q3 2021), $0.17 (Q2 2021), and $0.21 (Q1 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.32 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 0.12 |
| Jun 30, 2021 | 0.17 |
| Mar 31, 2021 | 0.21 |
| Dec 31, 2020 | -0.74 |
| Sep 30, 2020 | -0.23 |
| Jun 30, 2020 | -0.44 |
| Mar 31, 2020 | -0.19 |
| Dec 31, 2019 | -1.45 |
| Dec 31, 2018 | -0.44 |
| Dec 31, 2017 | 0.70 |